v3.26.1
Share Based Awards (Tables)
 6 Months Ended
Jun. 30, 2026
Share-Based Payment Arrangement [Abstract]  
Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions
The range of assumptions used to calculate the fair value of options granted during the six months ended June 30, 2026 was:
Exercise Price
$13.06 – 15.14
Stock price on date of grant
13.06 – 14.10
Risk-free interest rate
3.81 – 4.06%
Dividend yield— 
Expected term (years)
5.87 – 6.00
Volatility
135.84 – 143.99%
Schedule of Options Activity
A summary of options activity under the Plan is as follows:
Shares
(in thousands)		Weighted-
Average
Exercise
Price		Weighted-
Average
Remaining
Contractual
Term
(in years)		Aggregate
Intrinsic
Value
(in thousands)
Outstanding as of December 31, 20254,701 $4.14 8.04$18,616 
Granted1,115 13.20 
Exercised(785)1.47 
Forfeited or expired(122)4.40 
Outstanding as of June 30, 20264,909 6.62 8.1922,652 
Exercisable as of June 30, 20262,011 $3.51 6.90$14,365 
Schedule of Restricted Stock Activity
A summary of restricted stock activity under the Plan is as follows:
Shares
(in thousands)		Weighted Average Grant-Date Fair Value Per
Share
Unvested and outstanding as of December 31, 20252,124 $5.67 
Granted1,174 11.62 
Vested(1,030)3.77 
Forfeited(103)7.91 
Unvested and outstanding as of June 30, 20262,165 $9.69 
Schedule of Stock Compensation Expense by Functional Operating Expense
Stock compensation expense for the six months ended June 30 by functional operating expense was (in thousands):
20262025
Research and development$1,476 $321 
Sales and marketing965 1,732 
General and administrative7,418 1,581 
Total$9,859 $3,634